Janssen Biotech, Inc.

Form 483 issued March 5, 2018 · Malvern, Pennsylvania

Inspection
Feb 21 – Mar 5, 2018
Investigator
Anita R. Michael
Observations
1
Pages
1
FEI number
3001610451

In short: On March 5, 2018, FDA issued a Form 483 with 1 observation to Janssen Biotech, Inc. in Malvern, Pennsylvania (FEI 3001610451) after an inspection that ran Feb 21 – Mar 5, 2018. The investigator was Anita R. Michael. Most observations concern quality system; the most-cited regulation is 21 CFR 211.192 (production record review).

At a glance

1 of 1 observations on this 483 concern quality system.

Quality system1

Most cited: 21 CFR 211.192 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Written records of investigations into the failure of the batch or any of it's components to…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Janssen Biotech, Inc.?

FDA listed 1 observation on this Form 483, mostly about quality system. The most-cited regulation is 21 CFR 211.192 (production record review). The opening words of each observation are shown on this page.

Who inspected Janssen Biotech, Inc.?

Anita R. Michael is named on this Form 483, for the inspection of Feb 21 – Mar 5, 2018. Each investigator has a profile showing what they cite most.

When was Janssen Biotech, Inc. inspected by FDA?

The inspection ran Feb 21 – Mar 5, 2018, and the Form 483 is dated March 5, 2018.

How do I get the full Form 483 for Janssen Biotech, Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free